New York Workplaces Will Require Naloxone Kits by 2026
New York private employers must stock opioid reversal medication starting December 13, 2026, to improve workplace safety.
Updated on Oct. 5, 2026 in Substance Abuse
Live Poll
Should private businesses be required by law to stock opioid overdose treatment medication?
Starting December 13, 2026, private employers in New York state subject to OSHA first-aid requirements will be mandated to keep opioid antagonist medication on-site. This measure aims to increase the availability of life-saving interventions in professional settings across the state.
Why it matters
The new law mandates that businesses prepare for potential opioid-related emergencies by stocking naloxone and training staff on its use. By incorporating these kits into standard first-aid protocols, the state aims to extend emergency response capabilities beyond clinical settings.
The state mandate follows a significant decline in opioid deaths in Onondaga County, where fatalities dropped from 186 in 2021 to 81 by 2025. While the regulatory framework establishes the requirement, specific dose counts for individual workplaces remain under investigation.
The players
New York State Department of Labor
The state agency responsible for overseeing labor standards and implementing the new workplace safety regulations.
The details
Employers are responsible for funding the naloxone kits, which typically retail for between $27 and $35 for a two-dose set. Under the new regulations, businesses must determine necessary supply levels based on their specific facility layout and workforce size. Companies are also encouraged to train at least one employee present during working hours to administer the medication, with New York Good Samaritan Law providing liability protection for those who do so.
Timeline
2021: Syracuse Cooperative Market began stocking naloxone.
2021-2025: Onondaga County opioid deaths declined from 186 to 81.
2022: Onondaga County began stocking mobile naloxone boxes.
September 23, 2026: New York Department of Labor released proposed regulations.
December 13, 2026: New state law becomes effective.
Health Landscape
This mandate builds upon the existing framework of the New York Good Samaritan Law, which provides crucial liability protections for those attempting to save lives during medical emergencies. It marks a broader shift toward integrating opioid harm-reduction tools directly into public and private workplace safety policies.
If you are an employer, you should begin reviewing your current first-aid inventory and consulting with your medical providers to prepare for the 2026 rollout. Employees can speak with their supervisors to identify who will receive training or where life-saving medication will be stored on-site.
The takeaway
Naloxone kits are an essential tool for workplace preparedness as New York updates its safety regulations. If you manage a business, consult your local labor or health office to stay updated on the finalized implementation guidelines before the December 2026 deadline.
Further reading
For more information on state-wide initiatives, visit Substance Abuse.
Live Poll
Should private businesses be required by law to stock opioid overdose treatment medication?
